Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

X4 Pharmaceuticals (XFOR) Other Accumulated Expenses (2018 - 2019)

X4 Pharmaceuticals' Other Accumulated Expenses history spans 2 years, with the latest figure at $280000.0 for Q2 2019.

  • For Q2 2019, Other Accumulated Expenses fell 36.65% year-over-year to $280000.0; the TTM value through Jun 2019 reached $280000.0, down 36.65%, while the annual FY2018 figure was $249000.0, N/A changed from the prior year.
  • Other Accumulated Expenses reached $280000.0 in Q2 2019 per XFOR's latest filing, up from $271000.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $442000.0 in Q2 2018 to a low of $249000.0 in Q4 2018.